Literature DB >> 31695177

A variant of neonatal progeroid syndrome, or Wiedemann-Rautenstrauch syndrome, is associated with a nonsense variant in POLR3GL.

Eliane Beauregard-Lacroix1, Smrithi Salian2, Hyunyun Kim2, Sophie Ehresmann2, Guylaine DʹAmours1, Julie Gauthier2,3,4, Virginie Saillour3,4, Geneviève Bernard5,6,7, Grant A Mitchell1,2,4, Jean-François Soucy1,3,4, Jacques L Michaud1,2,4, Philippe M Campeau8,9.   

Abstract

Neonatal progeroid syndrome, also known as Wiedemann-Rautenstrauch syndrome, is a rare condition characterized by severe growth retardation, apparent macrocephaly with prominent scalp veins, and lipodystrophy. It is caused by biallelic variants in POLR3A, a gene encoding for a subunit of RNA polymerase III. All variants reported in the literature lead to at least a partial loss-of-function (when considering both alleles together). Here, we describe an individual with several clinical features of neonatal progeroid syndrome in whom exome sequencing revealed a homozygous nonsense variant in POLR3GL (NM_032305.2:c.358C>T; p.(Arg120Ter)). POLR3GL also encodes a subunit of RNA polymerase III and has recently been associated with endosteal hyperostosis and oligodontia in three patients with a phenotype distinct from the patient described here. Given the important role of POLR3GL in the same complex as the protein implicated in neonatal progeroid syndrome, the nature of the variant identified, our RNA studies suggesting nonsense-mediated decay, and the clinical overlap, we propose POLR3GL as a gene causing a variant of neonatal progeroid syndrome and therefore expand the phenotype associated with POLR3GL variants.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31695177      PMCID: PMC7080780          DOI: 10.1038/s41431-019-0539-6

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  6 in total

Review 1.  tRNA dysregulation and disease.

Authors:  Esteban A Orellana; Elisabeth Siegal; Richard I Gregory
Journal:  Nat Rev Genet       Date:  2022-06-09       Impact factor: 59.581

2.  MAF1, a repressor of RNA polymerase III-dependent transcription, regulates bone mass.

Authors:  Ellen Phillips; Naseer Ahmad; Li Sun; James Iben; Christopher J Walkey; Aleksandra Rusin; Tony Yuen; Clifford J Rosen; Ian M Willis; Mone Zaidi; Deborah L Johnson
Journal:  Elife       Date:  2022-05-25       Impact factor: 8.713

Review 3.  RNA Polymerases I and III in development and disease.

Authors:  Kristin En Watt; Julia Macintosh; Geneviève Bernard; Paul A Trainor
Journal:  Semin Cell Dev Biol       Date:  2022-04-11       Impact factor: 7.499

4.  A Case of Wiedemann-Rautenstrauch Syndrome With Fatal Hyperkalemic Renal Faliure.

Authors:  Mohamed A Ghamry; Rehab Salah; Eslam I Galal; Shereen Henin; Monica Dobs
Journal:  Cureus       Date:  2022-09-19

5.  Two novel mutations of COL1A1 in fetal genetic skeletal dysplasia of Chinese.

Authors:  Ruibing Li; Jianan Wang; Longxia Wang; Yanping Lu; Chengbin Wang
Journal:  Mol Genet Genomic Med       Date:  2020-01-03       Impact factor: 2.183

6.  Whole-exome sequencing reveals POLR3B variants associated with progeria-related Wiedemann-Rautenstrauch syndrome.

Authors:  Shao-Wen Wu; Lin Li; Fan Feng; Li Wang; Yuan-Yuan Kong; Xiao-Wei Liu; Chenghong Yin
Journal:  Ital J Pediatr       Date:  2021-07-21       Impact factor: 2.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.